Average Co-Inventor Count = 6.31
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Boehringer Ingelheim International Gmbh (8 from 1,536 patents)
2. Ablynx N.v. (3 from 163 patents)
3. Morphosys Ag (1 from 88 patents)
12 patents:
1. 12221487 - Nucleic acids encoding CX3CR1-binding polypeptides comprising immunoglobulin single variable domains
2. 11384151 - CX3CR1-binding polypeptides comprising immunoglobulin single variable domains
3. 11149086 - KV1.3 binding immunoglobulins
4. 10385134 - CX3CR1-binding polypeptides comprising immunoglobulin single variable domains
5. 9783612 - CX3CR1-binding polypeptides
6. 9637542 - CX3CR1-targeting imaging agents and their use in the diagnosis and treatment of disease
7. 9458235 - Method for treating a CX3CR1-associated disease with CX3CR1-binding polypeptides
8. 9090695 - Antibodies for guanylyl cyclase receptors
9. 9035029 - CX3CR1-binding polypeptides comprising immunoglobulin single variable domains
10. 9034822 - Methods of using antibodies during anticoagulant therapy of dabigatran and/or related compounds
11. 8821871 - Anticoagulant antidotes comprising antibodies that bind dabigatran and/or related compounds and methods of use thereof
12. 8486398 - Anticoagulant antidotes comprising antibodies that bind dabigatran and/or related compounds